Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
Tomas Kirchhoff(Memorial Sloan Kettering Cancer Center), Fleur Hammet(Monash Health), Chen‐Yang Shen(State Key Laboratory of Chemical Engineering), Angela Cox, Marjanka K. Schmidt(University of Cambridge), Chia‐Ni Hsiung(Tri-Service General Hospital), Hiltrud Brauch(German Cancer Research Center), Peter Schürmann(Hannover Re (Germany)), Laura van ‘t Veer, Clare Turnbull(Institute of Cancer Research), Thilo Dörk(Hannover Re (Germany)), Annegien Broeks, Celine M Vachon(Mayo Clinic in Florida), Antonis C. Antoniou(Weatherford College), Alison M. Dunning(University of Cambridge), Daehee Kang(Seoul National University), Henrik Flyger(University of Copenhagen), Malcolm Reed(Yorkshire Cancer Research), Olivia Fletcher(Breast Cancer Care), Ute Hamann(German Cancer Research Center), Linde M. Braaf(The Netherlands Cancer Institute), Stig E. Bojesen(University of Copenhagen), Mia M. Gaudet(Cancer Prevention Institute of California), Barbara Burwinkel(German Cancer Research Center), Børge G. Nordestgaard(Gentofte Hospital), Xianshu Wang(Kunming University of Science and Technology), Manjeet K. Humphreys(University of Cambridge), Jyh-Cherng Yu(Tri-Service General Hospital), Janet E. Olson(Cornell University), Dong‐Young Noh(Seoul National University), Melissa C. Southey(The University of Melbourne), Nazneen Rahman(Institute of Cancer Research), Pei-Ei Wu(Institute of Biomedical Sciences, Academia Sinica), Anthony Renwick(Institute of Cancer Research), Sei‐Hyun Ahn(Ulsan College), Lesley McGuffog(University of Cambridge), Sheila Seal(Institute of Cancer Research), Ian W. Brock(University of Sheffield), John L. Hopper(The University of Melbourne), Johann H. Karstens(Medizinische Hochschule Hannover), Yon‐Dschun Ko(University of Bonn), Fergus J. Couch(Mayo Clinic), Graeme Elliott(University of Sheffield), Lorna J. Gibson(London School of Hygiene & Tropical Medicine), Keun-Young Yoo(Seoul National University), Peter Hillemanns(Medizinische Hochschule Hannover), Julian Peto(University of Helsinki), Nichola Johnson(Institute of Cancer Research)
Cited by 13
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k